Close

Zealand Pharma (ZEAL) receives first FDA approval and prepares for launch of Zegalogue injection

Go back to Zealand Pharma (ZEAL) receives first FDA approval and prepares for launch of Zegalogue injection
(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High
Open $17.59    52 Week Low
Day High $17.59    P/E N/A 
Day Low $17.59    EPS
Volume 14,777